Cat. No. 3530
Chemical Name: 4-(Diphenylmethoxy)-1-(3-2H-tetrazo
Biological ActivityOrally active and specific inhibitor of human hematopoietic prostaglandin D synthase (H-PGDS) (IC50 = 6 μM). Antiallergic and anti-inflammatory; displays antiasthmatic activity and potent antihistaminic properties in vivo.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Datasheet
Aritake et al (2006) Structural and functional characterization of HQL-79, an orally selective inhibitor of human hematopoietic prostaglandin D synthase. J.Biol.Chem. 281 15277. PMID: 16547010.
Mohri et al (2006) Prostaglandin D2-mediated microglia/astrocyte interaction enhances astrogliosis and demyelination in twitcher. J.Neurosci. 26 4383. PMID: 16624958.
Matsushita et al (1998) Pharmacological studies on the novel antiallergic drug HQL-79: II. Elucidation of mechanisms for antiallergic and antihistaminic effects. Jpn.J.Pharmacol. 78 11. PMID: 9804057.
If you know of a relevant reference for this product please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses HQL 79 from Tocris? If so please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: HQL 79, supplier, HQL79, specific, hematopoietic, prostaglandin, D, synthase, HPGDS, inhibitors, inhibits, antiallergic, anti-inflammatory, Tocris Bioscience, Other Synthase/Synthetase Inhibitor products
Find multiple products by catalog number
New Products in this Area
Potent farnesyl diphosphate (FPP) synthase inhibitorBz 423
ATP synthase inhibitor; proapoptotic
April 10 - 13, 2017